89 related articles for article (PubMed ID: 24651441)
1. KiSS-1 Modulation by Epigenetic Agents Improves the Cisplatin Sensitivity of Lung Cancer Cells.
Beretta GL; Alampi D; Corno C; Carenini N; Corna E; Perego P
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732265
[TBL] [Abstract][Full Text] [Related]
2. Dihydroberberine exhibits synergistic effects with sunitinib on NSCLC NCI-H460 cells by repressing MAP kinase pathways and inflammatory mediators.
Dai B; Ma Y; Wang W; Zhan Y; Zhang D; Liu R; Zhang Y
J Cell Mol Med; 2017 Oct; 21(10):2573-2585. PubMed ID: 28444871
[TBL] [Abstract][Full Text] [Related]
3. The combination of methionine adenosyltransferase 2A inhibitor and methyltransferase like 3 inhibitor promotes apoptosis of non-small cell lung cancer cells and produces synergistic anti-tumor activity.
Xuan YF; Lu S; Ou YJ; Bao XB; Huan XJ; Song SS; Miao ZH; Wang YQ
Biochem Biophys Res Commun; 2024 Jul; 716():150011. PubMed ID: 38704890
[TBL] [Abstract][Full Text] [Related]
4. Syrosingopine and UK5099 synergistically suppress non-small cell lung cancer by activating the integrated stress response.
Li Y; Song Y; Shi Z; Hou H; Yu Y; Pan F; Ji J; Chen Z
Cell Death Dis; 2024 Jun; 15(6):431. PubMed ID: 38898028
[TBL] [Abstract][Full Text] [Related]
5. Theranostic etoposide phosphate/indium nanoparticles for cancer therapy and imaging.
Srinivas R; Satterlee A; Wang Y; Zhang Y; Wang Y; Huang L
Nanoscale; 2015 Nov; 7(44):18542-18551. PubMed ID: 26489694
[TBL] [Abstract][Full Text] [Related]
6. Pharmaco-transcriptomic correlation analysis reveals novel responsive signatures to HDAC inhibitors and identifies Dasatinib as a synergistic interactor in small-cell lung cancer.
Yang H; Sun B; Xu K; He Y; Zhang T; Hall SRR; Tan ST; Schmid RA; Peng RW; Hu G; Yao F
EBioMedicine; 2021 Jul; 69():103457. PubMed ID: 34224975
[TBL] [Abstract][Full Text] [Related]
7. PPMP, a novel tubulin-depolymerizing agent against esophageal cancer in patient-derived tumor xenografts.
Sheng Y; Liu K; Wu Q; Oi N; Chen H; Reddy K; Jiang Y; Yao K; Li H; Li W; Zhang Y; Saleem M; Ma WY; Bode AM; Dong Z; Dong Z
Oncotarget; 2016 May; 7(21):30977-89. PubMed ID: 27129160
[TBL] [Abstract][Full Text] [Related]
8. Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors.
Grohmann C; Walker F; Devlin M; Luo MX; Chüeh AC; Doherty J; Vaillant F; Ho GY; Wakefield MJ; Weeden CE; Kamili A; Murray J; Po'uha ST; Weinstock J; Kane SR; Faux MC; Broekhuizen E; Zheng Y; Shield-Artin K; Kershaw NJ; Tan CW; Witchard HM; Ebert G; Charman SA; Street I; Kavallaris M; Haber M; Fletcher JI; Asselin-Labat ML; Scott CL; Visvader JE; Lindeman GJ; Watson KG; Burgess AW; Lessene G
Cell Death Dis; 2021 Mar; 12(3):268. PubMed ID: 33712556
[TBL] [Abstract][Full Text] [Related]
9. Drug screening approach combines epigenetic sensitization with immunochemotherapy in cancer.
Facciotto C; Casado J; Turunen L; Leivonen SK; Tumiati M; Rantanen V; Kauppi L; Lehtonen R; Leppä S; Wennerberg K; Hautaniemi S
Clin Epigenetics; 2019 Dec; 11(1):192. PubMed ID: 31829282
[TBL] [Abstract][Full Text] [Related]
10. Chb-M', an Inhibitor of the RUNX Family Binding to DNA, Induces Apoptosis in
Hirose Y; Sato S; Hashiya K; Ooga M; Bando T; Sugiyama H
J Med Chem; 2024 Jun; 67(11):9165-9172. PubMed ID: 38803164
[TBL] [Abstract][Full Text] [Related]
11. [cDNA microarray technique on screening multi-drug resistance-related genes of human non-small cell lung cancer].
Liu M; Li C; Yan A; Cai L
Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):322-5. PubMed ID: 20677558
[TBL] [Abstract][Full Text] [Related]
12. JNK1-dependent antimitotic activity of thiazolidin compounds in human non-small-cell lung and colon cancer cells.
Teraishi F; Wu S; Sasaki J; Zhang L; Davis JJ; Guo W; Dong F; Fang B
Cell Mol Life Sci; 2005 Oct; 62(19-20):2382-9. PubMed ID: 16179969
[TBL] [Abstract][Full Text] [Related]
13. Role of Indole Scaffolds as Pharmacophores in the Development of Anti-Lung Cancer Agents.
Dhuguru J; Skouta R
Molecules; 2020 Apr; 25(7):. PubMed ID: 32244744
[TBL] [Abstract][Full Text] [Related]
14. Curcumin induces apoptosis and inhibits angiogenesis in murine malignant mesothelioma.
Zhang C; Hao Y; Wu L; Dong X; Jiang N; Cong B; Liu J; Zhang W; Tang D; De Perrot M; Zhao X
Int J Oncol; 2018 Dec; 53(6):2531-2541. PubMed ID: 30272283
[TBL] [Abstract][Full Text] [Related]
15. Novel Natural Product- and Privileged Scaffold-Based Tubulin Inhibitors Targeting the Colchicine Binding Site.
Dong M; Liu F; Zhou H; Zhai S; Yan B
Molecules; 2016 Oct; 21(10):. PubMed ID: 27754459
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Novel Tricyclic Thiazepine Derivatives as Anti-Drug-Resistant Cancer Agents by Combining Diversity-Oriented Synthesis and Converging Screening Approach.
Xiang J; Zhang Z; Mu Y; Xu X; Guo S; Liu Y; Russo DP; Zhu H; Yan B; Bai X
ACS Comb Sci; 2016 May; 18(5):230-5. PubMed ID: 27082930
[TBL] [Abstract][Full Text] [Related]
17. From fighting depression to conquering tumors: a novel tricyclic thiazepine compound as a tubulin polymerization inhibitor.
Mu Y; Liu Y; Xiang J; Zhang Q; Zhai S; Russo DP; Zhu H; Bai X; Yan B
Cell Death Dis; 2016 Mar; 7(3):e2143. PubMed ID: 26986511
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Two- and Three-Dimensional RNAi Screening Identifies PI3K Inhibition as a Complement to MEK Inhibitor AS703026 for Combination Treatment of Triple-Negative Breast Cancer.
Lee J; Galloway R; Grandjean G; Jacob J; Humphries J; Bartholomeusz C; Goodstal S; Lim B; Bartholomeusz G; Ueno NT; Rao A
J Cancer; 2015; 6(12):1306-19. PubMed ID: 26640591
[TBL] [Abstract][Full Text] [Related]
19. Synergistic action by multi-targeting compounds produces a potent compound combination for human NSCLC both in vitro and in vivo.
Zhang C; Zhai S; Li X; Zhang Q; Wu L; Liu Y; Jiang C; Zhou H; Li F; Zhang S; Su G; Zhang B; Yan B
Cell Death Dis; 2014 Mar; 5(3):e1138. PubMed ID: 24651441
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
